Citation tools
"Application of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, Following Administration of an Oral Radiolabeled Microtracer Dose in Humans." Drug Metabolism and Disposition
(2023):
DMD-AR-2022-001100.
Web. 22 Mar. 2023.